Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs

  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 3,
  • 1,
  • 1,
  • 4,
  • 4,
  • 1,
  • 1 and
  • 1, 2, 3Email author
Journal of Translational Medicine201412:126

https://doi.org/10.1186/1479-5876-12-126

  • Received: 6 May 2014
  • Accepted: 6 May 2014
  • Published:

The original article was published in Journal of Translational Medicine 2014 12:13

Correction

After publishing this article [1], we noted mistake in the spelling of co-author Rajesh Mukthavaram’s names. The corrected co author name has been included to the author list.

Notes

Authors’ Affiliations

(1)
Translational Neuro-Oncology Laboratories, Moores Cancer Center, UC San Diego, La Jolla, CA 92093, USA
(2)
Department of Neurosciences, UC San Diego, La Jolla, CA 92093, USA
(3)
Moores Cancer Center, UC san Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA
(4)
CellWorks Inc, Irvine, CA, USA

References

  1. Jiang P, Mukthavavam R, Chao Y, Bharati IS, Fogal V, Pastorino S, Cong X, Nomura N, Gallagher M, Abbasi T, Vali S, Pingle SC, Makale M, Kesari S: Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs. J Transl Med. 2014, 12: 13-10.1186/1479-5876-12-13.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

Advertisement